dipyridamole has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Excerpt | Relevance | Reference |
---|---|---|
"Dipyridamole was infused, and coronary sinus blood samples were obtained after 15 minutes or coincident with termination of SVT." | 2.68 | Endogenous adenosine is an antiarrhythmic agent. ( Belardinelli, L; Conti, JB; Curtis, AB; Utterback, DB, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conti, JB | 1 |
Belardinelli, L | 1 |
Utterback, DB | 1 |
Curtis, AB | 1 |
1 trial available for dipyridamole and Atrioventricular Nodal Reentrant Tachycardia
Article | Year |
---|---|
Endogenous adenosine is an antiarrhythmic agent.
Topics: Adenosine; Adult; Dipyridamole; Electrocardiography; Female; Humans; Male; Middle Aged; Tachycardia, | 1995 |